Orakl Oncology, a 2023 startup spun off from Gustave Roussy Institute, focuses on merging data and biology to develop new cancer drugs. Using AI technologies in clinical trials, Orakl creates personalized treatments for patients. Their avatar models blend patient data with tissues, targeting colorectal and pancreatic cancers. O-Predict and O-Validate products forecast and validate drug responses for developers and biotech companies, with recent funding from Singular VC to drive commercialization towards revolutionizing precision medicine discovery.

HUB2, a fintech startup in Ivory Coast, secured $8.5M in funding to become the 'Stripe for Francophone Africa'. Founded by Ashley Gauzere, it offers payment infrastructure services to neobanks, payment companies, and more. Serving 55 fintech companies, HUB2 aims to process €1 billion in transactions this year and expand regionally.

Blackrock marked down its investment in Automattic by 10% in its latest quarterly report. The initial value of $41.7 per share was adjusted to $37.5 per share. This came after Automattic blocked WP Engine's access to WordPress.org, leading to a legal dispute. Blackrock holds only 0.6% of Automattic with no voting rights.